Orion Market Research Report European Pharmaceutical Contract Manufacturing Mar | Page 2

estimated to progress with a high CAGR during the forecast period (2018-2023). This market is growing
significantly due to cost-effective production, increased inventory and so forth that are otherwise major
concerns for the pharmaceutical manufacturers. In addition, rapid turnaround time to introduce new drugs to
the market is also a critical concern for pharmaceutical companies. Additionally, significant pharmaceutical R&D
spending by European economies, increasing demand for generic drugs and the presence of major players are
further contributing towards the market growth.
Browse the full report of European Pharmaceutical Contract Manufacturing Market by Manufacturing
Process Type (Sterile Manufacturing, Non-Sterile Manufacturing), by Product Type (Over-The-Counter
(OTC) Drugs, Active Pharmaceutical Ingredients (API), Finished Dosage Formulation, Others), by Route
of Administration (Oral Administration, Inhaled Administration, Parenteral Administration, Others), by
Service (R&D, Manufacturing, Non-Clinical Service Such as Supply Chain Management) – Global Trends,
Size,
Share,
Growth,
Industry
Analysis
and
Forecast,
2018-2023
at
https://www.omrglobal.com/industry-reports/european-pharmaceutical-contract-manufacturing-
market/
Furthermore, European pharmaceutical contract manufacturing market is segmented on the basis of
manufacturing process type, product type, route of administration, service. The report provides detailed &
insightful chapters which include market overview, key findings, strategic recommendations, market
estimations, market determinants, key company analysis, market insights, company profiling, market
segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global European Pharmaceutical Contract Manufacturing Market by Manufacturing Process Type
• Sterile Manufacturing
• Non-sterile Manufacturing
2. Global European Pharmaceutical Contract Manufacturing Market by Product Type
• Over-The-Counter (OTC) Drugs
• Active Pharmaceutical Ingredients (API)
• Finished Dosage Formulation
• Solid Dose
• Liquid Dose
• Injectable Dose
• Others (Nutritional Products and Packaging)
3. Global European Pharmaceutical Contract Manufacturing Market by Route of Administration
• Oral Administration
• Inhaled Administration
• Parenteral Administration
• Others (Rectal and Vaginal)